Technical Analysis for STAB - Statera Biopharma Inc

Grade Last Price % Change Price Change
F 0.0003 0.00% 0.0000
STAB closed unchanged on Monday, September 25, 2023, on 51 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Flat

Date Alert Name Type % Chg
Expansion Breakdown Bearish Swing Setup 0.00%
Jack-in-the-Box Bearish Bearish Swing Setup 0.00%
Stochastic Buy Signal Bullish 0.00%
Narrow Range Bar Range Contraction 0.00%
Upper Bollinger Band Touch Strength 0.00%
Below Lower BB Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Expansion Breakdown Bearish Swing Setup 0.00%
Jack-in-the-Box Bearish Bearish Swing Setup 0.00%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Rose Above 20 DMA about 11 hours ago
Rose Above 10 DMA about 11 hours ago
Rose Above Upper Bollinger Band about 11 hours ago
Rose Above Lower Bollinger Band about 11 hours ago
Fell Below Lower Bollinger Band about 11 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Statera Biopharma Inc Description

Statera BioPharma, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses, and cancers based on a proprietary platform designed to rebalance the body's immune system and restore homeostasis. The company is developing therapies designed to directly elicit within patients a response of antigen-specific killer T-cells and antibodies, thereby activating essential immune defenses against autoimmune, inflammatory, infectious diseases, and cancers. It has clinical programs for Crohn's disease (STAT-201), hematology (Entolimod), pancreatic cancer (STAT-401), and COVID-19 (STAT-205), as well as fibromyalgia and multiple sclerosis. The company was formerly known as Cytocom, Inc. and changed its name to Statera Biopharma, Inc. in September 2021. Statera Biopharma, Inc. is based in Fort Collins, Colorado.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Medical Specialties Biopharmaceutical Clinical Medicine Infectious Diseases Cancers Immunology Autoimmune Diseases Antibodies Immunotherapy Immunotherapies Cancer Treatments Multiple Sclerosis Fibromyalgia Crohn's Disease Pancreatic Cancer Virotherapy Inflammatory Autoimmunity

Is STAB a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 0.0485
52 Week Low 0.0003
Average Volume 37,780
200-Day Moving Average 0.0000
50-Day Moving Average 0.0050
20-Day Moving Average 0.0003
10-Day Moving Average 0.0003
Average True Range 0.0007
RSI (14) 50.00
ADX 5.57
+DI 23.8095
-DI 22.6190
Chandelier Exit (Long, 3 ATRs) -0.0018
Chandelier Exit (Short, 3 ATRs) 0.0024
Upper Bollinger Bands 0.0003
Lower Bollinger Band 0.0003
Percent B (%b) 0.0
BandWidth 0.0000
MACD Line -0.0010
MACD Signal Line -0.0016
MACD Histogram 0.0005
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0003
Resistance 3 (R3) 0.0003 0.0003 0.0003
Resistance 2 (R2) 0.0003 0.0003 0.0003 0.0003
Resistance 1 (R1) 0.0003 0.0003 0.0003 0.0003 0.0003
Pivot Point 0.0003 0.0003 0.0003 0.0003 0.0003
Support 1 (S1) 0.0003 0.0003 0.0003 0.0003 0.0003
Support 2 (S2) 0.0003 0.0003 0.0003 0.0003
Support 3 (S3) 0.0003 0.0003 0.0003
Support 4 (S4) 0.0003